1. 138: TIMING AND DEGREE OF NEUTRALIZING ANTIBODY DEVELOPMENT AFTER PFIZER-BIONTECH VACCINATION. (16th December 2021) Authors: Pepe, Paul; Antevy, Peter; Marty, Aileen; Jui, Jonathan; Cabral, Maricar; Rosenberg, Lauren; Crowe, Remle; Scheppke, Kenneth Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 138: TIMING AND DEGREE OF NEUTRALIZING ANTIBODY DEVELOPMENT AFTER PFIZER-BIONTECH VACCINATION. (January 2022) Authors: Pepe, Paul; Antevy, Peter; Marty, Aileen; Jui, Jonathan; Cabral, Maricar; Rosenberg, Lauren; Crowe, Remle; Scheppke, Kenneth Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 327: DOCUMENTING THE TIMING AND KEY FACTORS IN POST-VACCINATION SARS-COV-2 HUMORAL ANTIBODY DEVELOPMENT. (16th December 2021) Authors: Pepe, Paul; Antevy, Peter; Marty, Aileen; Jui, Jonathan; Cabral, Maricar; Rosenberg, Lauren; Crowe, Remle; Scheppke, Kenneth Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 327: DOCUMENTING THE TIMING AND KEY FACTORS IN POST-VACCINATION SARS-COV-2 HUMORAL ANTIBODY DEVELOPMENT. (January 2022) Authors: Pepe, Paul; Antevy, Peter; Marty, Aileen; Jui, Jonathan; Cabral, Maricar; Rosenberg, Lauren; Crowe, Remle; Scheppke, Kenneth Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗